PET/CT in Radiotherapy Planning for Head and Neck Cancer
The use of PET/CT as an adjunct in radiotherapy planning is an attractive option in head and neck cancer (HNC) for several reasons. First, with potentially better identification of the disease extent i.e. staging, the risk of geographical miss of radiation delivery to the gross tumour volume (GTV) i...
Main Authors: | Katie eNewbold, Ceri ePowell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00189/full |
Similar Items
-
Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
by: C. Pisani, et al.
Published: (2021-03-01) -
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer
by: Beat Bojaxhiu, et al.
Published: (2022-08-01) -
Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation
by: Austin J. Iovoli, et al.
Published: (2021-03-01) -
Clinical Utility of Second-Look FDG PET-CT to Stratify Incomplete Metabolic Response Post (Chemo) Radiotherapy in Oropharyngeal Squamous Cell Carcinoma
by: Sarah Billingsley, et al.
Published: (2023-01-01) -
Use of <sup>18</sup>F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck
by: Viktoras Rudžianskas, et al.
Published: (2018-12-01)